Macrophage inflammatory protein-1α analogue

N/A

Report date: 2022/03/22 09:42:13

Base Information

Drug NameMacrophage inflammatory protein-1α analogue
Drug Alias NamenagrestipBB-10010eMIP
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunosuppressantsMitosis inhibitorsC-C chemokine receptor type 1 modulators +[5] 
TargetsC-C chemokine receptor type 1C-C chemokine receptor type 4C-C chemokine receptor type 5
Therapy Area/IndicationsLeukemia, MyeloidHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVernalis Plc
Active IndicationsN/A
Inactive IndicationsLeukemia, MyeloidHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A